159 related articles for article (PubMed ID: 30604899)
1. Treatment of acquired haemophilia with recombinant porcine factor VIII: A successful strategy in a patient with unstable angina.
Owen M; Gidley G; Horn EH
Haemophilia; 2019 Mar; 25(2):e94-e97. PubMed ID: 30604899
[No Abstract] [Full Text] [Related]
2. Unexpected pharmacokinetics of recombinant porcine factor VIII in a patient with acquired factor VIII deficiency and spontaneous epidural haematoma.
Shatzel JJ; Azar S; Scherber R; Gay N; Deloughery TG; VanSandt A; Kruse-Jarres R; Recht M; Taylor JA
Haemophilia; 2017 Sep; 23(5):e453-e456. PubMed ID: 28664642
[No Abstract] [Full Text] [Related]
3. Cardiac surgery in a patient with haemophilia A.
Eren A; Friedl R; Hannekum A; Gulbins H
Thorac Cardiovasc Surg; 2006 Apr; 54(3):212-4. PubMed ID: 16639687
[TBL] [Abstract][Full Text] [Related]
4. Successful management of refractory haematuria with recombinant porcine factor VIII replacement for paediatric congenital haemophilia A with high-titre inhibitor.
Jain S; Gupta S; Ambrusko SJ; Shapiro A
Haemophilia; 2017 Jul; 23(4):e358-e361. PubMed ID: 28474428
[No Abstract] [Full Text] [Related]
5. Porcine recombinant factor VIII: an additional weapon to handle anti-factor VIII antibodies.
Mannucci PM; Franchini M
Blood Transfus; 2017 Jul; 15(4):365-368. PubMed ID: 27483484
[TBL] [Abstract][Full Text] [Related]
6. Successful bleeding control with recombinant porcine factor VIII in reduced loading doses in two patients with acquired haemophilia A and failure of bypassing agent therapy.
Stemberger M; Möhnle P; Tschöp J; Ney L; Spannagl M; Reincke M
Haemophilia; 2016 Sep; 22(5):e472-4. PubMed ID: 27480782
[No Abstract] [Full Text] [Related]
7. Laboratory monitoring issues in recombinant porcine FVIII replacement in acquired haemophilia A.
Vanguru VR; Kershaw G; Konda M; Chen VM
Haemophilia; 2018 Mar; 24(2):e70-e74. PubMed ID: 29418045
[No Abstract] [Full Text] [Related]
8. Recombinant porcine factor VIII: a new installment of a long story.
Mannucci PM
Haemophilia; 2015 Mar; 21(2):149-151. PubMed ID: 25655769
[No Abstract] [Full Text] [Related]
9. Acquired haemophilia A treated with recombinant porcine factor VIII: a single centre UK experience.
Khan D; Raza-Burton S; Baker P; Harper S; Beavis J; Desborough M; Shapiro S
Br J Haematol; 2020 May; 189(4):e130-e133. PubMed ID: 32141061
[No Abstract] [Full Text] [Related]
10. Porcine factor VIII.
Giangrande PL
Haemophilia; 2012 May; 18(3):305-9. PubMed ID: 22531020
[No Abstract] [Full Text] [Related]
11. Experience with highly purified porcine factor VIII in a patient with haemophilia A and a factor VIII inhibitor.
Colvin BT; Ainsworth M; Buckley C
Clin Lab Haematol; 1983; 5(1):55-9. PubMed ID: 6406130
[TBL] [Abstract][Full Text] [Related]
12. Relationship between factor VIII replacement therapy and joint damage in severe haemophilia.
Lowe GD
Blood Coagul Fibrinolysis; 1997 Aug; 8 Suppl 1():S3-5. PubMed ID: 9351528
[TBL] [Abstract][Full Text] [Related]
13. Highly purified porcine factor VIII in haemophilia A with inhibitors to factor VIII.
Mayne EE; Madden M; Crothers IS; Ingles T
Br Med J (Clin Res Ed); 1981 Jan; 282(6260):318. PubMed ID: 6780009
[No Abstract] [Full Text] [Related]
14. Factor VIII assays in haemophilia a patients treated with ReFacto.
Sukhu K; Harrison P; Keeling D
Br J Haematol; 2003 Apr; 121(2):379-80. PubMed ID: 12694265
[No Abstract] [Full Text] [Related]
15. After the SIPPET study: Position paper of the CoMETH, the French society of haemophilia.
Lebreton A; Castet S; Falaise C; Rugeri L; Schved JF; Wibaut B
Haemophilia; 2018 Mar; 24(2):e55-e57. PubMed ID: 29316084
[No Abstract] [Full Text] [Related]
16. On the treatment of hemorrhage in patients with hemophilia and associated inhibitors.
Tarantino M; Aledort L
Transfusion; 2001 Dec; 41(12):1628-9. PubMed ID: 11778084
[No Abstract] [Full Text] [Related]
17. The use of recombinant factor VIII in the management of hemophilia.
Mannucci PM; Gringeri A
Ric Clin Lab; 1991; 21(1):1-7. PubMed ID: 1907760
[TBL] [Abstract][Full Text] [Related]
18. Recombinant porcine factor VIII use in bleed treatment in non-severe haemophilia A inhibitor patients: Dosing strategies and efficacy.
Ellsworth P; Chen SL; Key N; Abajas Y; Ma A
Haemophilia; 2021 Jan; 27(1):e147-e150. PubMed ID: 32842162
[No Abstract] [Full Text] [Related]
19. Chronic myelomonocytic leukaemia associated with acquired haemophilia A: case report and literature review.
Liang Y; Lu RN; Wang R; Zhang JF; Su W; Li JY; Zhang SJ; Lu H
Haemophilia; 2015 Jul; 21(4):e341-3. PubMed ID: 25982484
[No Abstract] [Full Text] [Related]
20. Who should receive recombinant factor VIII?
Giangrande PL
Blood Coagul Fibrinolysis; 1997 Aug; 8 Suppl 1():S25-7. PubMed ID: 9351533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
